OSIP def-14A is out. As we know, Dr. Webb went with the Solvay and proprietary KDUS project. This is his listing in the proxy, guess it's at least encouraging that he was added to the Axiom SAB in '99?
Yes, that's stretching. But, for what it's worth, here's the bio.....
DAVID R. WEBB, PH.D., was appointed Vice President, Discovery Research in
August 1999. Prior to joining the Corporation, Dr. Webb was Vice President of
Research and Chief Scientific Officer of Cadus Pharmaceutical Corporation from
1995 to 1999. From 1989 to 1996, Dr. Webb was a Consulting Professor of Cancer
Biology at Stanford University. From 1990 to 1995, Dr. Webb was a Distinguished
Scientist and Director, Institute of Immunology and Biological Sciences, Syntex,
Inc. and from 1987 to 1990, a Distinguished Scientist, Department of Molecular
Immunology, Syntex, Inc. Dr. Webb is presently an adjunct professor of
Microbiology and Immunology at New York Medical College. Dr. Webb has been a
member of the Board of Directors of Axiom Biotechnologies, Inc. since 1998 and a
member of its Scientific Advisory Board since 1999. |
